Welcome. How can we help?
30 Day Trial


Founded in 1992, ORTHOWORLD® is the only provider of strategic intelligence in the world solely focused on the global orthopaedic market. Its singular mission is helping orthopaedic companies and individuals improve their performance.

Highly specialized product offerings such as ORTHOWORLD Membership, ORTHOFLASH®, market reports, ORTHOPRENEUR®, BONEZONE® and OMTEC® empower industry participants to respond to challenges, maximize opportunities and more aggressively expand their orthopaedic businesses. We welcome the opportunity to assist you.


  • 10:00 a.m. Amedica (AMDA) received a notification from NASDAQ of an additional 180-day grace period (to 2/15/16) to regain compliance with NASDAQ’s $1.00 minimum bid requirement. The NASDAQ letter does not impact AMDA's NASDAQ listing at this time. (Source: Amedica Corporation)
  • 2:30 p.m. Tyber Medical received FDA 510(k) clearance for the TyWedgeOpening Osteotomy Wedge titanium plasma sprayed PEEK wedge implant. (Source: Tyber Medical, LLC)
  • 4:30 p.m. LDR closed its public offering of 2.3 shares of common stock priced at $40/share for total net proceeds of ~US $86.5MM. (Source: LDR Holding Corporation)
Read More

Articles of Interest All Articles

FDA Extends UDI Deadlines Following Database Security Issues

FDA extended the upcoming UDI deadlines by one month after it detected undisclosed security vulnerability with the UDI database. Manufacturers expected to submit labeling and data information by September 24 now have until October 24.